Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 18Recruiting 6Terminated 5Withdrawn 4Unknown 4Active not recruiting 3

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Recurrence 8Lymphoma, Non-Hodgkin 6Multiple Myeloma 5Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Small Cell Lung Carcinoma 1Neoplasms, Plasma Cell 1Neoplasms, Experimental 1Neoplasms by Histologic Type 1Lymphomatoid Granulomatosis 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, B-Cell 1Leukemia 1Immune System Diseases 1Burkitt Lymphoma 1

Interventions

Rituximab 57Cyclophosphamide 40Vincristine 26Prednisone 25Doxorubicin 22Cytarabine 18Lenalidomide 17Etoposide 17Gemcitabine 12Melphalan 8Filgrastim 8Cisplatin 8zanubrutinib 7Peripheral Blood Stem Cell Transplantation 7Oxaliplatin 7N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7Methotrexate 7Ifosfamide 7Carmustine 7R-CHOP protocol 6fludarabine phosphate 5Vindesine 5Radiotherapy 5Dexamethasone 5Decitabine 5Busulfan 5ibrutinib 4Methylprednisolone 4Epirubicin 4Cyclosporine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large B-Cell, Diffuse × Bendamustine Hydrochloride × Clear all
NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

Sheba Medical Center

Phase 2 Unknown
72 enrolled
Lymphoid

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02758925 2016-05-04

CyBeR-Lymph

University Hospital, Caen

Phase 2 Unknown
78 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02753062 2016-04-27

PTLD

Asan Medical Center

Phase 2 Unknown
22 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02134262 2014-11-06

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Jichi Medical University

Phase 1/2 Unknown
18 enrolled
Lymphoid

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡